Philip O Ponce MD (He/Him)
HIV/AIDS Medicine, Transplant/Immunocompromised States, STD Medicine
Assistant Director/Medical Monitor Pneumococcal Vaccines Pfizer VRD
Join to View Full Profile
500 Arcola RdCollegeville, PA 19426
Phone+1 210-567-7000
Dr. Ponce is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Philip Ponce is a medical professional specializing in Infectious Disease, with subspecialties in HIV/AIDS Medicine, Transplant/Immunocompromised States, and STD Medicine. He is currently based in Collegeville, PA. He completed his residency in Internal Medicine at the University of California (San Francisco) and a Fellowship in Infectious Disease at Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School. He is currently an Assistant Director at Pfizer in Vaccine Clinical Research and Development.
He was previously the Medical Director of Kind Clinic San Antonio, a community clinic focused on HIV and STI care, HIV and STI prevention, and gender-affirming care sponsored by Texas Health Action. He was also the founding Medical Director of the University Health / UT Health Science Center at San Antonio Transplant ID consultation service.
He has several publications in prominent journals about COVID-19 treatment strategies.
Clinical Expertise
- HIV/AIDS, Sexually transmitted infections, LGBT health, Primary care, Vaccines, Transplant infectious disease
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 2016 - 2018
University of California (San Francisco)Residency, Internal Medicine, 2006 - 2009
Perelman School of Medicine at the University of PennsylvaniaClass of 2006
Certifications & Licensure
CA State Medical License 2008 - 2024
TX State Medical License 2018 - 2024
MD State Medical License 2019 - 2019
MA State Medical License 2016 - 2018
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 75 citationsBaricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.Cameron R Wolfe, Kay M Tomashek, Thomas F Patterson, Carlos A Gomez, Vincent C Marconi
The Lancet. Respiratory Medicine. 2022-09-01 - 105 citationsEfficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phas...Andre C. Kalil, Aneesh K. Mehta, Thomas F Patterson, Nathaniel B. Erdmann, Carlos A. Gomez
The Lancet. Respiratory Medicine. 2021-10-18 - 11 citationsRemdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 - A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.Catharine I. Paules, Shannon K. Gallagher, Rekha R. Rapaka, Richard T. Davey, Sarah B Doernberg
Clinical Infectious Diseases. 2021-08-11
Press Mentions
The Future of MonkeypoxNovember 28th, 2022- ‘Desperate Need’: San Antonio Doctors Use COVID-Positive Donor Organs for Kidney, Liver TransplantsSeptember 2nd, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
